Juno Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
Juno Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $31 million sold in a notice filed in 2017.
Juno Therapeutics at a glance
What does Juno Therapeutics do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $31.1 million sold (2017).
A site under this name is registered with the FDA by Bristol Myers Squibb Company.
Frequently asked questions about Juno Therapeutics
Where is Juno Therapeutics headquartered?
Juno Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Juno Therapeutics do?
Juno Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Juno Therapeutics founded?
The earliest incorporation on record for Juno Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences